Elderly Patients Surgical Site Infection Phenotypes Identification
Launched by WEIDONG MI · Sep 21, 2024
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Backgrounds:
With the widespread use of prophylactic antibiotics during perioperative period and the continuous promotion of minimally invasive non-cardiac surgery type such as laparoscopic and thoracoscopic surgery, the incidence of superficial Surgical Site Infection (SSI) has been significantly reduced. Organ/deep SSI has become the dominant type of SSI. Currently, the classification of SSI is limited to the above location from shallow to deep, the epidemiological and clinical characteristics of SSI after non-cardiac surgery in elderly patients are still inadequately defined.
Objective...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 65 years;
- • 2. Patients undergoing surgeries not involving local anesthesia.
- Exclusion Criteria:
- • 1. Patients undergoing neurosurgery or cardiac surgery;
- • 2. Patients with preoperative infections (including pneumonia, SSIs, UTIs, and bloodstream infections);
- • 3. Uncertain type of operation
About Weidong Mi
Weidong Mi is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapies and improving patient outcomes, Weidong Mi collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials across various therapeutic areas. The organization emphasizes ethical standards, regulatory compliance, and patient safety, ensuring that all studies are designed to yield meaningful results while prioritizing the well-being of participants. Through its commitment to scientific excellence and collaboration, Weidong Mi aims to contribute significantly to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported